Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

202255 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Haematology

Volume 9, Issue 10, pp. e733-e744

Field-Weighted Citation Impact: 8.26